Literature DB >> 11733842

Anaplastic meningioma: case report.

A Falavigna1, J A Santos, L Chimelli, F A Ferraz, A de P Bonatelli Ad.   

Abstract

Intracranial meningiomas continue to challenge our best clinical efforts to eliminate them once discovered and deemed appropriate for treatment. Malignant meningiomas constitute 10% to 15% of all meningiomas and limited information exists regarding adjuvant treatment. The external whole brain irradiation is recommended. Traditional chemotherapy has proven ineffective; thus, new chemotherapeutic agents and new methods of delivery should be developed. Immunotherapy may be considered for patients with malignant meningiomas when all others previous treatment have failed. We report a case of anaplastic papillary meningioma. A 67-year-old man presented with partial complex seizures, headache and aggressiveness. A computerized tomography and magnetic resonance image demonstrated a large left temporo-occipital mass with diffuse contrast enhancement and extensive surrounding edema. A left temporo-occipital flap was performed. The tumor and the infiltrated dura were radically removed. Postoperatively, the patient remained neurologically intact. The treatment was complemented by external whole brain radiation.

Entities:  

Mesh:

Year:  2001        PMID: 11733842     DOI: 10.1590/s0004-282x2001000600019

Source DB:  PubMed          Journal:  Arq Neuropsiquiatr        ISSN: 0004-282X            Impact factor:   1.420


  2 in total

1.  Cystic meningioma: unusual imaging appearance of a common intracranial tumor.

Authors:  Amit Mittal; Kennith F Layton; S Sam Finn; George J Snipes; Michael J Opatowsky
Journal:  Proc (Bayl Univ Med Cent)       Date:  2010-10

2.  Immunohistochemical expression of h-telomerase reverse transcriptase in canine and feline meningiomas.

Authors:  Luciana Mandrioli; Serena Panarese; Alessandro Cesari; Maria Teresa Mandara; Paolo Stefano Marcato; Giuliano Bettini
Journal:  J Vet Sci       Date:  2007-06       Impact factor: 1.672

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.